| Dr James Keith Bailey, MD | |
|
301 Flynn Dr, Milbank, SD 57252-1508 | |
| (605) 432-4587 | |
| (605) 432-4580 |
| Full Name | Dr James Keith Bailey |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 301 Flynn Dr, Milbank, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619943255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 10765 (South Dakota) | Primary |
| Entity Name | Georgia Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952746638 PECOS PAC ID: 4082853262 Enrollment ID: O20130619000316 |
News Archive
Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.
RegeneRx Biopharmaceuticals, Inc. announced today that it has been awarded a $3 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352, an injectable formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4, for patients who have suffered an acute myocardial infarction, or AMI, commonly known as a heart attack.
Senomyx, Inc., a leading company in using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage and flavor industries, announced today that it has entered into a new collaborative agreement with PepsiCo, Inc. related to Senomyx's Salt Taste Program.
"There is currently a $3.6 billion funding gap on malaria in Africa, according to the Roll Back Malaria Partnership, whose board concluded its 23rd meeting in Dakar, Senegal, on December 7," Devex's "Development Newswire" blog reports.
Despite technological advances, discrimination against consumers inhibited by disabilities or disadvantaged by personal circumstances remains a significant problem. Many people today find themselves excluded by mainstream, day-to-day services on which they rely, such as banks, utilities, telecoms, health services and local authority providers. Their vulnerability can be hidden, a consequence of personal trauma or a health condition, or temporary resulting from a job loss. These are complex issues for organizations to identify and respond to appropriately.
› Verified 9 days ago
| Entity Name | Erx Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760823082 PECOS PAC ID: 9335037571 Enrollment ID: O20130930000326 |
News Archive
Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.
RegeneRx Biopharmaceuticals, Inc. announced today that it has been awarded a $3 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352, an injectable formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4, for patients who have suffered an acute myocardial infarction, or AMI, commonly known as a heart attack.
Senomyx, Inc., a leading company in using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage and flavor industries, announced today that it has entered into a new collaborative agreement with PepsiCo, Inc. related to Senomyx's Salt Taste Program.
"There is currently a $3.6 billion funding gap on malaria in Africa, according to the Roll Back Malaria Partnership, whose board concluded its 23rd meeting in Dakar, Senegal, on December 7," Devex's "Development Newswire" blog reports.
Despite technological advances, discrimination against consumers inhibited by disabilities or disadvantaged by personal circumstances remains a significant problem. Many people today find themselves excluded by mainstream, day-to-day services on which they rely, such as banks, utilities, telecoms, health services and local authority providers. Their vulnerability can be hidden, a consequence of personal trauma or a health condition, or temporary resulting from a job loss. These are complex issues for organizations to identify and respond to appropriately.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Keith Bailey, MD 301 Flynn Dr, Milbank, SD 57252-1508 Ph: (605) 432-4587 | Dr James Keith Bailey, MD 301 Flynn Dr, Milbank, SD 57252-1508 Ph: (605) 432-4587 |
News Archive
Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.
RegeneRx Biopharmaceuticals, Inc. announced today that it has been awarded a $3 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352, an injectable formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4, for patients who have suffered an acute myocardial infarction, or AMI, commonly known as a heart attack.
Senomyx, Inc., a leading company in using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage and flavor industries, announced today that it has entered into a new collaborative agreement with PepsiCo, Inc. related to Senomyx's Salt Taste Program.
"There is currently a $3.6 billion funding gap on malaria in Africa, according to the Roll Back Malaria Partnership, whose board concluded its 23rd meeting in Dakar, Senegal, on December 7," Devex's "Development Newswire" blog reports.
Despite technological advances, discrimination against consumers inhibited by disabilities or disadvantaged by personal circumstances remains a significant problem. Many people today find themselves excluded by mainstream, day-to-day services on which they rely, such as banks, utilities, telecoms, health services and local authority providers. Their vulnerability can be hidden, a consequence of personal trauma or a health condition, or temporary resulting from a job loss. These are complex issues for organizations to identify and respond to appropriately.
› Verified 9 days ago
Stephanie Lyn Dargatz, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Flynn Dr, Milbank, SD 57252 Phone: 605-432-4587 | |
Doron Michael Spierer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 603 S Dakota St, Milbank, SD 57252 Phone: 888-733-4428 Fax: 605-432-5669 | |
Kevin L Bjordahl, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 803 E Milbank Ave, Milbank, SD 57252 Phone: 605-432-4587 Fax: 605-432-4580 | |
Dr. Nanci J Vanpeursem, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 803 E Milbank Ave, Milbank, SD 57252 Phone: 605-432-4587 Fax: 605-432-4580 |